Barbara Mosiewicz-Madejska
Research Subjects
Barbara Mosiewicz-Madejska has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Jerzy Mosiewicz
Department of Internal Diseases, Medical University, Lublin, Poland
2 shared publications - Wojciech Myśliński
Chair and Department of Internal Medicine, Medical University, Lublin, Poland
2 shared publications Andrzej Dybała
1st Military Hospital in Lublin, Department of Internal Medicine, Lublin, Poland
1 shared publication- Andrzej Jaroszyński
Collegium Medicum, Jan Kochanowski University, 25-516 Kielce, Poland
1 shared publication - Andrzej Prystupa
Department of Internal Medicine, Medical University, Lublin, Poland
1 shared publication - Elżbieta Reichert
Individual Specialist Medical Practice, Lublin, Poland
1 shared publication
Latest Publications
- Open Access
- 21 December 2023
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
- Vol. 30 (4) , 737-742
Selected routine laboratory tests in the clinical assessment of patients with obstructive sleep apnea
Introduction: Obstructive sleep apnea (OSA) is a chronic disease characterized by repetitive complete or partial occlusion of the upper airways during sleep with respiratory muscle effort, which leads to consecutive apneas and hypopneas. Obstruction of the upper airways during sleep leads to...
- 21 December 2023
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
- Vol. 30 (4) , 737-742
Open AccessSelected routine laboratory tests in the clinical assessment of patients with obstructive sleep apnea
Introduction: Obstructive sleep apnea (OSA) is a chronic disease characterized by repetitive complete or partial occlusion of the upper airways during sleep with respiratory muscle effort, which leads to consecutive apneas and hypopneas. Obstruction of the upper airways during sleep leads to...
- Open Access
- 5 September 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (9) , e0221255
Obstructive sleep apnea may increase the risk of Alzheimer's disease
Amyloid-β 1–40 (Aβ 1–40) and amyloid-β 1–42 (Aβ 1–42) are the proteins known to be involved in the pathogenesis of Alzheimer’s disease (AD)–the most common cause of dementia in the elderly. Hypoxia is suspected to be one of conditions associated with Aβ plasma level increase. A common reason of hypoxia is obstructive sleep apnea (OSA), characterized by recurrent episodes of apnea. The aim of the study was to evaluate plasma Aβ 1–40 and Aβ 1–42 concentrations in patients with OSA. Patients with suspected OSA (n = 112) underwent polygraphic examinations Patients with confirmed OSA (n = 81) showed apnea/hypopnea index greater than or equal to 5. Mild and moderate form of the disease was defined when AHI was 5–30 (n = 38, OSA+), severe–when AHI was >30 (n = 43, OSA++). Individuals with AHI<5 (n = 31) served as control group (OSA-). Aβ 1–40 concentrations in OSA++ (191.1 pg/ml) group was significantly (p<0.05) higher compared with OSA- (76.9 pg/ml) and OSA+ (159.4 pg/ml) and correlated with selected parameters of hypoxemia severity. There were no differences in Aβ 1–42 concentration between the groups. In patients with severe OSA Aβ 1–40 plasma concentrations are significantly higher compared with OSA- and OSA+ and seem to be related to hypoxia severity, which may indicate increased risk of AD development in this group of patients.
- 5 September 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (9) , e0221255
Open AccessObstructive sleep apnea may increase the risk of Alzheimer's disease
Amyloid-β 1–40 (Aβ 1–40) and amyloid-β 1–42 (Aβ 1–42) are the proteins known to be involved in the pathogenesis of Alzheimer’s disease (AD)–the most common cause of dementia in the elderly. Hypoxia is suspected to be one of conditions associated with Aβ plasma level increase. A common reason of hypoxia is obstructive sleep apnea (OSA), characterized by recurrent episodes of apnea. The aim of the study was to evaluate plasma Aβ 1–40 and Aβ 1–42 concentrations in patients with OSA. Patients with suspected OSA (n = 112) underwent polygraphic examinations Patients with confirmed OSA (n = 81) showed apnea/hypopnea index greater than or equal to 5. Mild and moderate form of the disease was defined when AHI was 5–30 (n = 38, OSA+), severe–when AHI was >30 (n = 43, OSA++). Individuals with AHI<5 (n = 31) served as control group (OSA-). Aβ 1–40 concentrations in OSA++ (191.1 pg/ml) group was significantly (p<0.05) higher compared with OSA- (76.9 pg/ml) and OSA+ (159.4 pg/ml) and correlated with selected parameters of hypoxemia severity. There were no differences in Aβ 1–42 concentration between the groups. In patients with severe OSA Aβ 1–40 plasma concentrations are significantly higher compared with OSA- and OSA+ and seem to be related to hypoxia severity, which may indicate increased risk of AD development in this group of patients.